Navegar por los elementos (3 total)

At ATTD 2025, the main topics were identifying the risk of developing type 1 diabetes, advances in inhaled insulin, and research into glucose-sensitive insulins, among other topics.

The FDA has developed a classification for CGM systems that divides them into those that require (complementary) or do not (non-complementary) the use of test strips for safe decision making.

In the new Abbott Diabetes Portal, leading specialists teach certified and on-demand courses on the latest advances in continuous glucose monitoring and technology applied to diabetes. Exclusively for health professionals.